14132.11. (Added by Stats. 2023, Ch. 329, Sec. 2.)
(a)Commencing on July 1, 2024, pharmacogenomic testing…#
(a) Commencing on July 1, 2024, pharmacogenomic testing shall be a covered benefit under the Medi-Cal program, subject to utilization controls and evidence-based clinical practice guidelines.
(b)“Pharmacogenomic testing” means laboratory genetic…#
(b) “Pharmacogenomic testing” means laboratory genetic testing that includes, but is not limited to, a panel test, to identify how a person’s genetics may impact the efficacy, toxicity, and safety of medications.
(c)This section shall be implemented only to the extent…#
(c) This section shall be implemented only to the extent that any necessary federal approvals have been obtained and federal financial participation is available and not otherwise jeopardized.